l9n/ Pennsylvania

2025–2026 Regular Session

Senate Bill 866

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

In the House of Representatives's Judiciary Committee since June 10, 2026.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

Its course

July 24, 2025 to June 10, 2026, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action10 actions on 6 days

In the SenateJul 24 to Jun 9320 days

Agriculture & Rural AffairsJul 24 to Jun 2313 days

AppropriationsJun 3 to Jun 85 days

In the House of RepresentativesFrom Jun 9

JudiciaryFrom Jun 10

Votes

Yeas to nays, as the General Assembly recorded them. Committee votes are set in.

  • Senate, third reading47–2

    Passed · Jun 9, 2026

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the Senate Jul 24 – Jun 9, 2026

  1. Sent to AGRICULTURE AND RURAL AFFAIRS
  2. AGRICULTURE AND RURAL AFFAIRS recommended it
  3. Read a second time
  4. Sent to APPROPRIATIONS
  5. APPROPRIATIONS recommended it
  6. Passed the Senate, 47 to 2

In the House of Representatives Jun 10, 2026

  1. Arrived in the House of Representatives
  2. Sent to JUDICIARY
All 10 actions, as published